secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARTIVION, INC. (AORT)
CIK:        0000784199
Form:       8-K
Filed at:   2023-08-03T23:59:59+00:00
Accession:  0000784199-23-000130
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Artivion Q2 revenue $89.3M (+11% YoY); raises FY revenue guidance to $342-350M
------------------------------------------------------------------------------

- Net loss ($3.4M) or ($0.08)/share; non-GAAP net income $2.3M ($0.06)/share.
- Non-GAAP adjusted EBITDA $13.8M, up 35% YoY.
- Aortic stent graft revenue +19% YoY; On-X +11% constant currency.
- Received $14.3M PerClot PMA approval milestone payment from Baxter.
- FY 2023 constant currency revenue growth guidance raised to 10%-12%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/784199/000078419923000130/0000784199-23-000130-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/784199/000078419923000130/aort-20230803.htm
  HTML page:      https://secwatch.observer/filing/0000784199-23-000130

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer